Author:
Su Deng-Huang,Chang Ying-Chun,Liao Shu-Lang,Chang Tien-Chun
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Reference14 articles.
1. Chang TC, Kao CSC, Huang KM (1992) Octreotide and Graves? ophthalmopathy and pretibial myxoedema. Br Med J 304:158
2. Chang TC, Yao WC, Chang CC (1992) Octreotide and urinary glycosaminoglycan in Graves? disease. Br Med J 304:1444
3. Fentiman IS, Balkwill FR, Thomas BS, Russell MJ, Todd I, Bottazzo GF (1988) An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer. Eur J Cancer Clin Oncol 24:1299?1303
4. Huet D, Entremont A, Hautecouverture M (2000) Basedow?s disease and interferon for hepatitis C. Recurrence as Basedow?s ophthalmopathy after interferon reintroduction. Presse Med 29:82
5. Krassas GE, Kaltsas T, Dumas A, Pontikides N, Tolis G (1997) Lanreotide in the treatment of patients with thyroid eye disease. Eur J Endocrinol 136:416?422
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Oncolytic Drugs;Drug-Induced Ocular Side Effects;2021
2. Eye Symptoms and Toxicities of Systemic Chemotherapy;The MASCC Textbook of Cancer Supportive Care and Survivorship;2018
3. Drug-induced ocular side effects;Drug-Induced Ocular Side Effects;2015
4. Eye Symptoms and Toxicities of Systemic Chemotherapy;The MASCC Textbook of Cancer Supportive Care and Survivorship;2010
5. Orbital and Periorbital Side Effects of Chemotherapy;Ophthalmic Oncology;2010